Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRACTSystemic lupus erythmatosus (SLE) is an autoimmune disease which involved many organs. One of its severe manifestations is lupus nephritis (LN). Treatment of LN consist of two phases, induction and maintenance. Inappropriate treatmen approach could increase morbidity and mortality in LN pantients. Renal flare is among many bad outcomes of LN that should be mitigated with an approciate therapuitec approach. Various guidelines stated usage of mycophenolate mofetil (MMF) or azathioprine (AZA) as an appropriate immunosuppresant in the maintenence phase"

"ABSTRAKSalmonella as a causative agent in septic bursitis is considered rare. We report a case of 56 years old male with history of renal transplantation and using mycophenolate mofetil, cyclosporine and methylprednisolone as maintenance, admitted due to 3 week fever associated with tenderness and swelling on left shoulder. Upon investigation, a diagnosis of septic bursitis was established. Salmonella enteritidis as the definitive causative agent was revealed. He was treated with meropenem 1g IV three times daily and levofloxacin 500 mg IV once a day for 3 weeks, followed by oral ciprofloxacin 500 mg twice a day for 2 weeks and oral metronidazole 500 mg three times a day for 1 week with a total duration of 5 weeks of antibiotics. On the subsequent follow up there was no recurrence episode of fever and the swelling of the left shoulder subsided, no tenderness noted and the patient has no limitation of range of movement. Since immunocompromised state complicates the management, the duration of therapy may twice longer than the typical management of septic bursitis. Salmonella as etiologic agent should be considered as differential in immunocompromised patient with septic bursitis."

"ABSTRAKSalmonella as a causative agent in septic bursitis is considered rare. We report a case of 56 years old male with history of renal transplantation and using mycophenolate mofetil, cyclosporine and methylprednisolone as maintenance, admitted due to 3 week fever associated with tenderness and swelling on left shoulder. Upon investigation, a diagnosis of septic bursitis was established. Salmonella enteritidis as the definitive causative agent was revealed. He was treated with meropenem 1g IV three times daily and levofloxacin 500 mg IV once a day for 3 weeks, followed by oral ciprofloxacin 500 mg twice a day for 2 weeks and oral metronidazole 500 mg three times a day for 1 week with a total duration of 5 weeks of antibiotics. On the subsequent follow up there was no recurrence episode of fever and the swelling of the left shoulder subsided, no tenderness noted and the patient has no limitation of range of movement. Since immunocompromised state complicates the management, the duration of therapy may twice longer than the typical management of septic bursitis. Salmonella as etiologic agent should be considered as differential in immunocompromised patient with septic bursitis."

"ABSTRACTBackground: the use of bioelectrical impedance analysis (BIA) is affected by the population setting, the type of BIA, and the cut-off point being used. The aim of this study was to determine the diagnostic performance of BIA to measure muscle mass in Indonesian elderly outpatients aged 60 years or more. Methods: a cross-sectional study was conducted at the Geriatric Clinic of Cipto Mangunkusumo Hospital from April to June 2018. The muscle mass was measured using BIA Tanita MC-780MA (Tokyo, Japan) with dual-energy x-ray absorptiometry (DXA) as the reference test. Analysis on the cut-off point was performed based on the Asian Working Group of Sarcopenia (AWGS) criteria and the new cut-off point. Results: from 120 subjects, 74 were female (61.7%). The diagnostic performance of BIA based on AWGS criteria only showed sensitivity and specificity of 79.2% and 66.7%. The diagnostic performance of BIA based on the new cut-off point showed sensitivity and specificity of 75% and 92.7%. The new cut-off point using BIA was found to be <6.9 kg/m2 in males (sensitivity 70.6%; specificity 82.8%) and <5 kg/m2 in females (sensitivity 85.7%; specificity 97%). Conclusion: the diagnostic performance of BIA Tanita MC-780MA (Tokyo, Japan) was good to measure muscle mass in Indonesian elderly outpatients using a new cut-off point of <6.9 kg/m2 for males and <5 kg/m2 for females."

"ABSTRAKZirkonium sebagai biomaterial logam mulai banyak diteliti dalam beberapa tahun ini. Sifat mekanis, biokompatibilitas, dan magnetic suscetibility yang baik menjadi pertimbangan digunakan zirkonium untuk aplikasi biomaterial. Namun demikian paduan zirkonium masih memiliki beberapa kekurangan sehingga dilakukan penelitian untuk mendapatkan sifat yang optimal dari paduan zirkonium. Pengaruh temperatur dan waktu sebagai parameter sinter untuk paduan Zr-8Mo-4Nb untuk aplikasi biomaterial menggunakan metalurgi serbuk telah diamati dalam penelitian ini. Densitas dan Porositas paduan telah diukur menggunakan Prinsip Archimedes. Mikrostuktur paduan diuji menggunakan X-Ray diffractometer (XRD), Secondary Electron Microscope (SEM), dan Mikroskop Optik (OM), kekerasan paduan juga diukur menggunakan Rockwell C, dan bioaktifitas menggunakan larutan SBF dilanjutkan dengan FTIR. Hasil penelitian menunjukan dengan peningkatan temperatur dan waktu tahan sinter, akan meningkatkan densitas, kekerasan serta menurunkan porositas paduan Zr-8Mo-4Nb. Selain itu paduan Zr-8Mo-4Nb juga memiliki sifat bioaktivitas yang baik dengan membentuk lapisan hidroksiapatit pada permukaan sampel

---

ABSTRACTZirconium as biomaterial has been widely researched in recent years. Mechanical properties, biocompatibility, and magnetic suscetibility well into consideration use zirconium for biomaterial applications. However, zirconium alloy still have some disadvantages, and the purpoes of this research to get the optimal properties of zirconium alloy. Effect of sintering temperature and holding time of Zr-4Nb-8Mo alloy for biomaterials application using powder metallurgy has been observed in this study. Density and porosity are measured using Archimedes principles. The microstructure was evaluated with X-Ray diffractometer (XRD), Secondary Electrone Microscope (SEM) and Optical Microscope (OM), hardness was measured with Rockwell C hardness. Bioactivity was tested with SBF solution continued with FTIR. The results showed that increasing sintering temperature and holding time will increase the density, hardness and reducce the porosity of Zr-4Nb-8Mo alloys. Furthermore Zr-8Mo-4Nb showed a good bioactivity indicated by hydroxyapatite formation on the surface."

"Background: Glucosamine, chondroitinsulfate are frequently used to prevent further joint degeneration in osteoarthritis (OA). Methylsulfonylmethane (MSM) is a supplement containing organic sulphur and also reported to slow anatomical joint progressivity in the knee OA. The MSM is often combined with glucosamine and chondroitin sulfate. However, there are controversies whether glucosamine chondroitin sulfate or their combination with methylsulfonylmethane could effectively reduce pain in OA. This study is aimed to compare clinical outcome of glucosamine chondroitin sulfate (GC), glucosamine chondroitin sulfate methylsulfonylmethane (GCM), and placeboin patients with knee osteoarthritis (OA) Kellgren Lawrence grade I II. Methods: a double blind, randomized controlled clinical trial was conducted on 147 patients with knee OA Kellgren Lawrence grade I II. Patients were allocated by permuted block randomization into three groups: GC (n=49), GCM (n=50), or placebo (n=48) groups. GC group received 1500 mg of glucosamine + 1200 mg of chondroitin sulfate + 500 mg of saccharumlactis; GCM group received 1500 mg of glucosamine + 1200 mg of chondroitin sulfate + 500 mg of MSM; while placebo group received three matching capsules of saccharumlactis. The drugs were administered once daily for 3 consecutive months VAS and WOMAC scores were measured before treatment, then at 4th, 8th and 12th week after treatment. Results: on statistical analysis it was found that at the 12th week, there are significant difference between three treatment groups on the WOMAC score (p=0.03) and on the VAS score (p=0.004). When analyzed between weeks, GCM treatment group was found statistically significant on WOMAC score (p=0.01) and VAS score (p<0.001). Comparing the score difference between weeks, WOMAC score analysis showed significant difference between GC, GCM, and placebo in week 4 (p=0.049) and week 12 (p=0.01). In addition, VAS score also showed significant difference between groups in week 8 (p=0.006) and week 12 (p<0.001). Conclusion: combination of glucosamine chondroitinsulfate methylsulfonylmethane showed clinical benefit for patients with knee OAK ellgren Lawrence grade I II compared with GC and placebo. GC did not make clinical improvement in overall groups of patients with knee OA Kellgren Lawrence grade I II."

"Latar Belakang: Tujuan studi ini adalah membandingkan terapi antara siklofosfamid dan mikofenolat mofetil pada remisi nefritis lupus melalui sebuah laporan kasus berbasis bukti (evidence-based case report) yang diperoleh dari telaah sistematis dan meta-analisis.Metode: Metode yang digunakan pada studi ini adalah laporan kasus berbasis bukti menggunakan telaah sistematis dan meta-analisis. Pertanyaan klinis adalah manakah terapi imunosupresan yang memberikan hasil lebih baik pada remisi nefritis lupus; siklofosfamid atau mikofenolat mofetil? Untuk menjawab pertanyaan tersebut, kami melakukan pencarian dari situs PubMed dengan kata kunci ?lupus nephritis AND mycophenolate mofetil AND cyclophosphamide? dengan batasan telaah sistematis dan/atau meta-analisis, bahasa Inggris, dan hanya melakukan perbandingan secara spesifik terhadap kedua obat.Hasil: Dari pencarian awal, kami memperoleh 11 artikel telaah sistematis dan/atau meta-analisis terkait terapi nefritis lupus. Satu artikel dieksklusi karena berbahasa Yahudi, empat artikel lain dieksklusi karena tidak spesifik melakukan perbandingan terhadap mikofenolat mofetil dan siklofosfamid sehingga diperoleh enam studi yang ikut serta dalam telaah kritis dan diskusi laporan kasus kami.Kesimpulan: Berdasarkan bukti-bukti ilmiah yang diperoleh, mikofenolat mofetil memberikan efektivitas yang sama (non-inferior) dengan siklofosfamid dalam mencapai remisi pada nefritis lupus, tetapi memiliki tingkat keamanan yang lebih baik daripada siklofosfamid. Pasien pada kasus mendapatkan mikofenolat mofetil dan telah menunjukkan perbaikan secara klinis ke arah remisi pada evaluasi pasca-rawat inap

---

Background: The aim of this case study is to compare the effectiveness between cyclophosphamide and mycophenolate mofetil to achieve remission of lupus nephritis in an evidence-based case report from meta-analyses.

Methods: Method in this case study is evidence-based case report using meta-analyses. Clinical question used in this paper is; which immunosuppressant gives better result in achieving remission in lupus nephritis patient: cyclophosphamide or mycophenolate mofetil? To answer this question, we search the evidence from PubMed with the keywords: ?lupus nephritis AND mycophenolate mofetil AND cyclophosphamide? with inclusion criteria of meta-analysis, written in English, and focused comparing cyclophosphamide and mycophenolate mofetil.

Results: From the searching method, we found 11 articles which is relevant. One has been excluded since it written in Hebrew, 4 articles excluded since are not focus answering the clinical question. At the end, 6 studies were included to the critical appraisal step.

Conclusion: Based on the evidences, mycophenolate mofetil is non-inferior to cyclophosphamide in achieving remission in lupus nephritis patients, but with the better safety profile. Patient in our case study get mycophenolate mofetil and shows better clinical condition towards remission as she are evaluated in the outpatient clinic."

"ABSTRACTBackground: sarcopenia is one of many geriatric problems that may lead to major clinical outcomes. Calf and thigh circumference have good correlation with muscle mass, whereas SARC-F questionnaire is very predictive of muscle function. There has not been a study that evaluates the diagnostic performance of calf and thigh circumference in combination with SARC-F questionnaire in detecting sarcopenia. The aim of this study was to investigate the diagnostic performance of calf and thigh circumference in combination with SARC-F questionnaire compared to standard diagnostic methods of sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) to predict sarcopenia in patient aged 60 years or older. METHODS: this cross-sectional study was conducted in Geriatric Clinic Cipto Mangunkusumo Hospital, Jakarta, Indonesia during April-June 2018. Analysis was performed using receiver operating characteristic (ROC) curve to determine the cut-off point as well as sensitivity (Sn), specificity (Sp), positive and negative predictive value (PPV and NPV), positive and negative likelihood ratio (LR+ and LR-) of calf and thigh circumference as an indicator of low muscle mass, and SARC-F questionnaire score to detect decreased muscle function. RESULTS: from 120 participants, there were 46 men (38.3%) and 74 women (61.7%). The combination of calf circumference with cut-off point below 34 cm in men and below 29 cm in women, thigh circumference below 49 cm in men and below 44 cm in women with SARC-F questionnaire score of ≥4 have Sn, Sp, PPV, NPV, LR+, and LR- of 15.79%; 99.01%; 75.00%; 86.21%; 15.95; and 0.85 respectively. CONCLUSION: combination of calf and thigh circumference with SARC-F questionnaire showed good diagnostic accuracy in predicting sarcopenia in elderly outpatients."